JAFCO Super V3 Investment Limited Partnership

JAFCO Super V3 Investment Limited Partnership discloses dealings in 2 companies, chiefly Sesen Bio, Inc. and Tracon Pharmaceuticals, Inc. We count 129 filings; the first trade dates from 11 February 2014 and the latest from 16 October 2015.

Both buying and selling appear: 2 purchases worth €3.9M, against 122 sales worth €5.6M. On balance, insiders were net sellers of €1.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises. Since January 2015: 1 purchase and 108 sales on the market.

On 19 October 2015 came the latest disclosure, an open-market sale for €13k in Tracon Pharmaceuticals, Inc. The most recent open-market purchase was published on 17 February 2015, 4,282 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.